stoxline Quote Chart Rank Option Currency Glossary
  
Bullfrog AI Holdings, Inc. Common Stock (BFRG)
2.7  0.24 (9.76%)    02-06 10:34
Open: 2.53
High: 2.79
Volume: 350,501
  
Pre. Close: 2.46
Low: 2.47
Market Cap: 24(M)
Technical analysis
2025-02-06 10:16:08 AM
Short term     
Mid term     
Targets 6-month :  3.44 1-year :  4.02
Resists First :  2.95 Second :  3.44
Pivot price 2.38
Supports First :  2.33 Second :  1.95
MAs MA(5) :  2.43 MA(20) :  2.32
MA(100) :  2.38 MA(250) :  2.75
MACD MACD :  0 Signal :  0
%K %D K(14,3) :  53.5 D(3) :  42.6
RSI RSI(14): 60
52-week High :  5.51 Low :  1.42
Price, MAs and Bollinger Bands

Price has closed above its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is BULLISH in short-term; and NEUTRAL in mid-long term.
[ BFRG ] has closed below upper band by 7.7%. Bollinger Bands are 5.8% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Stock Price Prediction
If tomorrow: Open lower Open higher
High: 2.55 - 2.56 2.56 - 2.57
Low: 2.31 - 2.32 2.32 - 2.34
Close: 2.44 - 2.46 2.46 - 2.48
Company Description

BullFrog AI Holdings, Inc., through its subsidiaries, operates as a digital biopharmaceutical company that focuses on artificial intelligence and machine learning (AI/ML) driven analysis of data sets in medicine and healthcare in the United States. It offers bfLEAP, an AI/ML platform for the analysis of preclinical and/or clinical data. The company also has licensing agreements with George Washington University for rights to use siRNA targeting Beta2-spectrin in the treatment of human diseases, including hepatocellular carcinoma, obesity, non-alcoholic fatty liver disease, and non-alcoholic steatohepatitis; and Johns Hopkins University for the use of a formulation of Mebendazole for the treatment of human cancer or neoplastic disease. BullFrog AI Holdings, Inc. was founded in 2017 and is based in Gaithersburg, Maryland.

Headline News

Fri, 31 Jan 2025
Bullfrog AI Announces Closing of $8.4 Million Initial Public Offering - ACCESS Newswire

Tue, 17 Dec 2024
BullFrog AI Announces Appointment of Chief Financial Officer -December 17, 2024 at 04:30 pm EST - Marketscreener.com

Mon, 21 Oct 2024
Bullfrog AI Announces Closing of Registered Direct Offering and Concurrent Private Placement for Aggregate Gross Proceeds of $3.13 Million - StockTitan

Wed, 17 Jan 2024
symbol__ Stock Quote Price and Forecast - CNN

Tue, 25 Apr 2023
If You're Bullish On Bullfrog AI, Consider The Warrants For A Superior Risk To Return Profile - Seeking Alpha

Tue, 14 Feb 2023
BFRGW - Bullfrog AI Holdings, Inc. Warrants Latest Stock News & Market Updates - StockTitan

Financial Analysis
Price to Book Value:
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Underperform
Price to Earnings:
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Underperform
Discounted cash flow:
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Neutral
Return on Assets:
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Underperform
Return on Equity:
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Underperform
Debt to Equity:
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Neutral
Stock Basics & Statistics
Exchange:
NASDAQ
Sector:
Healthcare
Industry:
Medical - Healthcare Information Services
Shares Out 0 (M)
Shares Float 9 (M)
Held by Insiders 4.23e+006 (%)
Held by Institutions 29.2 (%)
Shares Short 200 (K)
Shares Short P.Month 0 (K)
Stock Financials
EPS -6.29e+006
EPS Est Next Qtrly 0
EPS Est This Year 0
EPS Est Next Year 0
Book Value (p.s.) 0
Profit Margin 0 %
Operating Margin -9 %
Return on Assets (ttm) 673.2 %
Return on Equity (ttm) -64.9 %
Qtrly Rev. Growth 65000 %
Gross Profit (p.s.) 0.1
Sales Per Share 0
EBITDA (p.s.) 0
Qtrly Earnings Growth -0.9 %
Operating Cash Flow 0 (M)
Levered Free Cash Flow -6 (M)
Stock Valuations
PE Ratio -0.01
PEG Ratio 0
Price to Book value 0
Price to Sales 654.05
Price to Cash Flow 0
Stock Dividends
Dividend 0
Forward Dividend 257400
Dividend Yield 0%
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.

StockChart iOS

StoxlineLite iOS

StoxlineLite iOS

OptionCalc iOS

StockChart Android

StoxlineLite Android

StoxlinePro Android

OptionCalc Android